Next generation probiotics (NGP) or live biotherapeutics are organisms that have been designed to be used as living medicines to treat, cure or diagnose disease. They differ from traditional probiotics in that they are likely to be registered under a drug regulatory framework. At present, conventional probiotics are used as either functional foods or as supplements, whereas next generation probiotics are mainly used as therapeutics and hence are subject to the full range of registration processes and clinical trials.
The next generation probiotics market is expected to gain further traction, with evolving applications which signifies the new genera of probiotics. The well recognized applications of next generation probiotics are drug administration, vaccine delivery, immunomodulation (boosting the immune system), psychobiotics (for the treatment of mental disorders), cancer treatment and prevention, stress tolerance, production of antimicrobial compounds, to understand the pathogenesis of enteric infections.
Market Dynamics
Market players are focused on raising funds from investors for the development of next generation probiotics which is expected to drive market growth over the forecast period. For instance, in May 2019, Whole Biome (now Pendulum), a biotechnology company, announced that it had secured US$ 35 million in Series B financing, which was funded by investor Sequoia Capital, a venture capital company and others. The company had used the funds to advance the commercialization of its patented product, expand its discovery pipeline, and scale clinical trials for their novel microbiome interventions.
Key features of the study:
- This report provides in-depth analysis of the global next generation probiotics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global next generation probiotics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global next generation probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation probiotics market
Detailed Segmentation:
- Global Next Generation Probiotics Market, By Bacterial Candidate:
- Akkermansia
- Clostridium species
- Bifidobacterium species
- Lactobacillus species
- Others (Faecalibacterium, Christensenella,etc.)
- Global Next Generation Probiotics Market, By Application:
- Weight Management
- Glucose Management
- Inflammatory Bowel Diseases
- Others (Obesity, Metabolic Diseases, etc.)
- Global Next Generation Probiotics Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Pendulum
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Amsterdam Winclove Probiotics
- Metabogen AB (Biogaia)
- Exeliom Biosciences
- TargEDys
- Hansen Holding A/S
- YSOPIA Bioscience
- A-Mansia Biotech
- Next Gen Probiotics
- Evolve Biosystems
- DuPont de Nemours, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
